HK1174662A1 - Plasmids and methods for peptide display and affinity-selection on virus- like particles of rna bacteriophages rna - Google Patents
Plasmids and methods for peptide display and affinity-selection on virus- like particles of rna bacteriophages rnaInfo
- Publication number
- HK1174662A1 HK1174662A1 HK13101590.7A HK13101590A HK1174662A1 HK 1174662 A1 HK1174662 A1 HK 1174662A1 HK 13101590 A HK13101590 A HK 13101590A HK 1174662 A1 HK1174662 A1 HK 1174662A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rna
- plasmids
- virus
- affinity
- particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/16011—Details ssRNA Bacteriophages negative-sense
- C12N2795/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/16011—Details ssRNA Bacteriophages negative-sense
- C12N2795/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/16011—Details ssRNA Bacteriophages negative-sense
- C12N2795/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/16011—Details ssRNA Bacteriophages negative-sense
- C12N2795/16041—Use of virus, viral particle or viral elements as a vector
- C12N2795/16042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33512109P | 2009-12-31 | 2009-12-31 | |
US33512009P | 2009-12-31 | 2009-12-31 | |
US33512209P | 2009-12-31 | 2009-12-31 | |
PCT/US2010/062638 WO2011082381A2 (fr) | 2009-12-31 | 2010-12-31 | Plasmides et procédés de présentation de peptides et de sélection par affinité sur des particules de type virus de bactériophages à arn |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1174662A1 true HK1174662A1 (en) | 2013-06-14 |
Family
ID=44227171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13101590.7A HK1174662A1 (en) | 2009-12-31 | 2013-02-05 | Plasmids and methods for peptide display and affinity-selection on virus- like particles of rna bacteriophages rna |
Country Status (9)
Country | Link |
---|---|
US (3) | US9365831B2 (fr) |
EP (1) | EP2519627B1 (fr) |
JP (1) | JP2013516181A (fr) |
CN (1) | CN102858960B (fr) |
BR (1) | BR112012016305A2 (fr) |
CA (1) | CA2785992C (fr) |
ES (1) | ES2578979T3 (fr) |
HK (1) | HK1174662A1 (fr) |
WO (1) | WO2011082381A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130149336A1 (en) * | 2011-10-27 | 2013-06-13 | Brian L. Hjelle | Methods for Screening Viral Like Particles and Identifying Neutralizing Epitopes and Related Vaccines, Constructs, and Libraries |
US9549976B1 (en) | 2012-11-16 | 2017-01-24 | Stc.Unm | Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles |
EP3043815A4 (fr) * | 2013-09-12 | 2017-06-14 | Stc.Unm | Vaccin contre le paludisme |
WO2015095355A2 (fr) | 2013-12-17 | 2015-06-25 | The Brigham And Women's Hospital, Inc. | Détection d'un anticorps dirigé contre un agent pathogène |
CN103923887A (zh) * | 2014-04-16 | 2014-07-16 | 辽宁医学院 | 含戊型肝炎病毒rna片段的假病毒颗粒及其制备方法 |
CN105755026B (zh) * | 2014-12-18 | 2020-06-23 | 天演药业(苏州)有限公司 | 过滤载体及其应用 |
EP3244915A1 (fr) | 2015-01-15 | 2017-11-22 | University of Copenhagen | Pseudo-particule virale à présentation efficace des épitopes |
US11129882B2 (en) | 2015-10-30 | 2021-09-28 | University Of Copenhagen | Virus like particle with efficient epitope display |
EP3408284A4 (fr) * | 2016-01-28 | 2019-08-14 | The Brigham and Women's Hospital, Inc. | Détection d'un anticorps dirigé contre un agent pathogène |
CN106806890A (zh) * | 2016-12-28 | 2017-06-09 | 中国医学科学院医学生物学研究所 | 重组人vegf多肽肿瘤疫苗 |
US20200239872A1 (en) * | 2017-03-13 | 2020-07-30 | Duke University | Antigen display system and methods for characterizing antibody responses |
WO2022169665A1 (fr) * | 2021-02-05 | 2022-08-11 | Unm Rainforest Innovations | Vaccins à particules de type virus bactériophage contre la protéine 1 non structurale de flavivirus |
EP4355882A2 (fr) | 2021-06-15 | 2024-04-24 | Modernatx, Inc. | Polynucléotides modifiés pour expression spécifique de type cellulaire ou micro-environnement |
CN114085930B (zh) * | 2022-01-21 | 2022-04-12 | 广州国家实验室 | 用于检测SARS-CoV-2核酸的SERS检测试剂盒及方法 |
TW202412818A (zh) | 2022-07-26 | 2024-04-01 | 美商現代公司 | 用於暫時控制表現之經工程化多核苷酸 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE286140T1 (de) | 2000-05-03 | 2005-01-15 | Emd Biosciences Inc | E. coli extrakt zur synthese von proteinen |
JP2004089069A (ja) * | 2002-08-30 | 2004-03-25 | Mitsubishi Chemicals Corp | 多コピー提示ファージの製造方法 |
JP4283563B2 (ja) | 2003-03-04 | 2009-06-24 | 積水化学工業株式会社 | 木質マットの搬送装置 |
US9803189B2 (en) * | 2006-08-23 | 2017-10-31 | Stc.Unm | Virus-like platform for rapid vaccine discovery |
-
2010
- 2010-12-31 CN CN201080065079.6A patent/CN102858960B/zh not_active Expired - Fee Related
- 2010-12-31 ES ES10841780.9T patent/ES2578979T3/es active Active
- 2010-12-31 JP JP2012547321A patent/JP2013516181A/ja active Pending
- 2010-12-31 EP EP10841780.9A patent/EP2519627B1/fr active Active
- 2010-12-31 BR BR112012016305A patent/BR112012016305A2/pt not_active Application Discontinuation
- 2010-12-31 CA CA2785992A patent/CA2785992C/fr not_active Expired - Fee Related
- 2010-12-31 WO PCT/US2010/062638 patent/WO2011082381A2/fr active Application Filing
- 2010-12-31 US US13/520,057 patent/US9365831B2/en active Active
-
2013
- 2013-02-05 HK HK13101590.7A patent/HK1174662A1/xx not_active IP Right Cessation
-
2016
- 2016-06-08 US US15/176,396 patent/US20160354459A1/en not_active Abandoned
-
2021
- 2021-04-29 US US17/244,255 patent/US20210338793A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20210338793A1 (en) | 2021-11-04 |
US20160354459A1 (en) | 2016-12-08 |
WO2011082381A2 (fr) | 2011-07-07 |
BR112012016305A2 (pt) | 2017-05-02 |
US9365831B2 (en) | 2016-06-14 |
EP2519627A4 (fr) | 2013-12-18 |
CN102858960B (zh) | 2014-11-26 |
EP2519627A2 (fr) | 2012-11-07 |
CA2785992C (fr) | 2019-10-08 |
US20120295813A1 (en) | 2012-11-22 |
WO2011082381A3 (fr) | 2011-12-22 |
CA2785992A1 (fr) | 2011-07-07 |
EP2519627B1 (fr) | 2016-03-30 |
JP2013516181A (ja) | 2013-05-13 |
ES2578979T3 (es) | 2016-08-03 |
CN102858960A (zh) | 2013-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1174662A1 (en) | Plasmids and methods for peptide display and affinity-selection on virus- like particles of rna bacteriophages rna | |
HK1199892A1 (en) | Modified mini-hepcidin peptides and methods of using thereof | |
ZA201403666B (en) | Engineered nucleic acids and methods of use thereof | |
EP2324113B8 (fr) | Particules similaires à un virus comportant des séquences d'acides aminés de capside composites pour une réactivité croisée améliorée | |
PL2635257T3 (pl) | Cząstki wirusopodobne (vlp) glikoproteiny wirusa wścieklizny | |
ZA201206832B (en) | Novel peptides and method for their preparation and use | |
EP2600901A4 (fr) | Acides nucléiques modifiés et leurs procédés d'utilisation | |
EP2581389A4 (fr) | Protéine de fusion d'exendine-4, son analogue, son procédé de préparation et son utilisation | |
ZA201209048B (en) | Apparatus and process of purification of proteins | |
EP2442829A4 (fr) | Compositions de peptides viraux structurés et procédés d'utilisation | |
EP2396343A4 (fr) | Vecteurs viraux modifiés et procédés de fabrication et d'utilisation de ceux-ci | |
EP2654540A4 (fr) | Appareil et procédé de contrôle du fonctionnement d'un dispositif de nettoyage | |
IL218474A0 (en) | Novel fusion proteins and method of expression thereof | |
IL209919A0 (en) | Process for preparing caspofungin and intermediates thereof | |
HUP0900319A2 (en) | New peptides, method of producing therof and use thereof | |
IL219913A0 (en) | New process for the preparation of tapentadol and intermediates thereof | |
HK1146471A1 (en) | Polypeptide derived from enterococcus and its use for vaccination | |
IL214762A0 (en) | Modifications of cupredoxin derives peptides and methods of use thereof | |
EP2484757A4 (fr) | Virus capable d'exprimer un épitope de -galactose, et procédé de production de vaccin | |
WO2010141845A8 (fr) | Peptides immunorégulateurs et procédés d'utilisation | |
EP2632487A4 (fr) | Vaccin viral et son procédé de préparation | |
EP2476753A4 (fr) | Produit de recombinaison recouvert d'une protéine constituant une coque virale et son procédé de production | |
AU2009903119A0 (en) | A method for preparation of a virus particle and/or virus-like particle | |
IL226187B (en) | Virus-like glycoprotein particles in rabies | |
AU2009902322A0 (en) | Methods and Apparatus for Detection of Particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20191231 |